Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeki Yagyu

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Cancer Science|May 19, 2025
Ligand-Based CAR-T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic MalignanciesManaka Shinagawa, Koichi Hirabayashi, Marina Fujioka, et al.
Frontiers in Oncology|August 22, 2025
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)Chikako Funasaka, Yoichi Naito, Hitomi Kubota, et al.
British Journal of Cancer|December 26, 2023
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancerHajime Kamiya, Shuhei Komatsu, Yusuke Takashima, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|November 13, 2025
Retrospective study of stage IV extracranial germ cell tumors: A report from the Japan Children's Cancer GroupYuki Arakawa, Yuya Sato, Shuichiro Uehara, et al.
Cancer Science|August 31, 2021
CD146 is a potential immunotarget for neuroblastomaSatoshi Obu, Katsutsugu Umeda, Hiroo Ueno, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Cancer Science|May 19, 2025
Ligand-Based CAR-T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic MalignanciesManaka Shinagawa, Koichi Hirabayashi, Marina Fujioka, et al.
Frontiers in Oncology|August 22, 2025
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)Chikako Funasaka, Yoichi Naito, Hitomi Kubota, et al.
British Journal of Cancer|December 26, 2023
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancerHajime Kamiya, Shuhei Komatsu, Yusuke Takashima, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|November 13, 2025
Retrospective study of stage IV extracranial germ cell tumors: A report from the Japan Children's Cancer GroupYuki Arakawa, Yuya Sato, Shuichiro Uehara, et al.
Cancer Science|August 31, 2021
CD146 is a potential immunotarget for neuroblastomaSatoshi Obu, Katsutsugu Umeda, Hiroo Ueno, et al.
Pageof 7